聚合甲基胺酸通过氧化压力介导的酸暴露在血小板中增强了前凝剂活性
1College of Pharmacy, Kangwon National University, Chuncheon 24341, Republic of Korea.
Toxics
|January 22, 2024
概括
聚乙烯瓜尼丁酸盐 (PHMG-p),一种消毒剂,触发了血小板前凝活动. 这种机制涉及氧化应激和,可能解释了与除菌剂有关的心血管疾病.
科学领域:
- 生物化学 生物化学
- 毒理学 毒理学 毒理学
- 心血管研究研究心血管研究
背景情况:
- 聚甲甘酸 (PHMG-p) 是一种广泛使用的生物杀伤剂.
- 在韩国,作为加湿器消毒剂 (HD) 的滥用导致致命的健康影响,包括心血管疾病.
- 导致HD相关心血管疾病的确切机制尚不清楚.
研究的目的:
- 调查PHMG-p诱导的血小板的前凝活性.
- 阐明PHMG-p诱导的血小板激活的潜在分子机制.
- 探索PHMG-p暴露与心血管疾病风险之间的联系.
主要方法:
- 评估PHMG-p对血小板脂素 (PS) 暴露的影响.
- 研究了脂转运体,细胞内,ATP水平和caspase-3激活的作用.
- 评估了氧化应激和线粒体功能障碍的影响.
- 利用抗氧化剂催化酶和化剂EGTA来逆转PHMG-p的作用.
主要成果:
- PHMG-p显著增加了血小板上的PS暴露.
- 这与失调的脂载体,细胞内升高,ATP耗尽和caspase-3激活有关.
- 氧化应激和线粒体功能障碍被确定为关键调解因素.
- 催化酶和EGTA治疗逆转了PHMG-p诱导的PS暴露和血栓生成.
- PHMG-p诱导了显著的血栓生成,表明了血小板前凝剂的激活.
结论:
- 通过涉及氧化应激和信号传递的机制,PHMG-p触发了血小板前凝激活.
- 这种血小板激活可能会导致湿器消毒剂暴露后观察到的前血栓风险和心血管疾病.
- 这些发现有助于更好地理解与PHMG-p暴露相关的健康风险.
更多相关视频
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
701
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
701
01:22Formation of the Platelet Plug
6.3K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.3K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
525
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
525
01:20Extrinsic and Intrinsic Pathways of Hemostasis
7.7K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.7K